HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Robert L Ferris Selected Research
Robert L Ferris Research Topics
Disease
195
Neoplasms (Cancer)
04/2024 - 11/2003
136
Squamous Cell Carcinoma of Head and Neck
05/2024 - 03/2004
96
Head and Neck Neoplasms (Head and Neck Cancer)
04/2024 - 01/2004
19
Neoplasm Metastasis (Metastasis)
01/2017 - 03/2004
13
Melanoma (Melanoma, Malignant)
03/2024 - 01/2017
13
Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2022 - 12/2004
13
Carcinogenesis
01/2021 - 03/2005
10
Thyroid Neoplasms (Thyroid Cancer)
05/2022 - 09/2007
9
Disease Progression
01/2023 - 01/2005
9
Carcinoma (Carcinomatosis)
01/2023 - 04/2005
7
Oropharyngeal Neoplasms
10/2022 - 12/2004
6
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
03/2024 - 08/2014
5
Fatigue
03/2024 - 06/2005
5
Deglutition Disorders (Dysphagia)
10/2022 - 01/2010
5
Inflammation (Inflammations)
12/2021 - 01/2006
5
Hemorrhage
01/2021 - 01/2016
4
Colorectal Neoplasms (Colorectal Cancer)
03/2024 - 08/2011
4
Infections
01/2021 - 10/2004
4
Squamous Cell Neoplasms (Squamous Cell Cancer)
12/2018 - 09/2014
4
Pemphigus (Pemphigus Vulgaris)
08/2013 - 03/2005
3
Pain (Aches)
01/2023 - 01/2017
3
Mucositis
01/2023 - 01/2010
3
Hypoxia (Hypoxemia)
01/2021 - 01/2014
3
Bites and Stings (Sting)
01/2020 - 01/2018
3
Margins of Excision
01/2018 - 01/2016
3
Sarcoma (Soft Tissue Sarcoma)
04/2017 - 12/2014
2
Dermatitis
03/2024 - 01/2022
2
Extranodal Extension
01/2023 - 01/2018
2
Lung Neoplasms (Lung Cancer)
01/2023 - 01/2014
2
Stomatitis
12/2022 - 10/2017
Drug/Important Bio-Agent (IBA)
47
Cetuximab (Erbitux)
FDA Link
03/2024 - 12/2007
35
Biomarkers (Surrogate Marker)
IBA
04/2024 - 03/2005
22
Monoclonal Antibodies
IBA
03/2024 - 12/2007
21
Proteins (Proteins, Gene)
FDA Link
11/2023 - 10/2004
21
ErbB Receptors (EGF Receptor)
IBA
08/2021 - 01/2007
19
Nivolumab
IBA
03/2024 - 11/2016
15
Neoplasm Antigens (Tumor Antigens)
IBA
01/2018 - 10/2004
12
Platinum
IBA
01/2023 - 11/2016
11
Immune Checkpoint Inhibitors
IBA
03/2024 - 01/2018
11
Cisplatin (Platino)
FDA Link
Generic
01/2024 - 05/2010
11
Cytokines
IBA
01/2018 - 03/2005
10
RNA (Ribonucleic Acid)
IBA
11/2023 - 03/2014
10
Ligands
IBA
01/2022 - 03/2004
8
DNA (Deoxyribonucleic Acid)
IBA
11/2023 - 04/2016
8
Vaccines
IBA
01/2022 - 06/2007
8
Peptides (Polypeptides)
IBA
07/2018 - 10/2004
8
Antigens
IBA
08/2013 - 03/2005
7
Chemokine Receptors
IBA
01/2012 - 03/2004
6
Antibodies
IBA
12/2019 - 03/2008
6
HLA Antigens (Human Leukocyte Antigens)
IBA
01/2019 - 01/2005
6
Epitopes
IBA
01/2019 - 11/2005
6
Histocompatibility Antigens Class I
IBA
01/2018 - 01/2005
6
Chemokines
IBA
01/2018 - 05/2005
6
Intercellular Signaling Peptides and Proteins (Growth Factors)
IBA
04/2017 - 06/2005
5
Ipilimumab
IBA
01/2023 - 10/2018
5
Carcinogens
IBA
01/2022 - 05/2008
5
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
01/2021 - 10/2011
5
Indicators and Reagents (Reagents)
IBA
01/2018 - 11/2009
4
Tumor Biomarkers (Tumor Markers)
IBA
01/2023 - 11/2009
4
T-Cell Antigen Receptors (T-Cell Receptor)
IBA
01/2023 - 07/2005
4
pembrolizumab
IBA
01/2022 - 01/2019
4
B7-H1 Antigen
IBA
01/2022 - 03/2016
4
HLA-A*02:01 antigen
IBA
07/2018 - 10/2004
4
HLA-A Antigens (HLA-A)
IBA
01/2018 - 12/2005
4
Messenger RNA (mRNA)
IBA
01/2018 - 05/2005
4
Docetaxel (Taxotere)
FDA Link
01/2017 - 12/2010
4
Panitumumab (Vectibix)
FDA Link
11/2016 - 12/2007
3
Fluorouracil (Carac)
FDA Link
Generic
01/2023 - 01/2019
3
NF-kappa B (NF-kB)
IBA
01/2022 - 01/2006
3
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
01/2022 - 03/2014
3
Interleukin-6 (Interleukin 6)
IBA
01/2022 - 10/2011
3
Small Interfering RNA (siRNA)
IBA
01/2021 - 11/2009
3
Hepatocyte Growth Factor (Growth Factor, Hepatocyte)
IBA
06/2020 - 10/2008
3
VTX-2337
IBA
11/2018 - 08/2013
3
Immunoglobulin G (IgG)
IBA
02/2018 - 01/2015
3
Interferons
IBA
01/2018 - 09/2014
3
Phosphotransferases (Kinase)
IBA
01/2018 - 09/2005
3
MicroRNAs (MicroRNA)
IBA
04/2017 - 04/2011
3
Mucins
IBA
03/2017 - 01/2016
3
Erlotinib Hydrochloride (CP 358,774)
FDA Link
01/2017 - 11/2012
3
Growth Factor Receptors
IBA
01/2017 - 03/2008
3
Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)
IBA
10/2016 - 06/2013
3
Codon (Codons)
IBA
05/2015 - 10/2010
3
Epidermal Growth Factor (EGF)
IBA
10/2014 - 01/2007
3
Calcium
IBA
08/2013 - 04/2011
2
Carboplatin (JM8)
FDA Link
Generic
01/2023 - 12/2019
2
Programmed Cell Death 1 Receptor
IBA
01/2023 - 01/2022
2
Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)
IBA
01/2022 - 11/2009
2
Type II Tumor Necrosis Factor Receptors
IBA
01/2022 - 01/2016
2
Steroids
IBA
01/2022 - 11/2003
Therapy/Procedure
91
Therapeutics
03/2024 - 11/2003
68
Immunotherapy
05/2024 - 01/2004
47
Radiotherapy
01/2024 - 04/2005
26
Drug Therapy (Chemotherapy)
01/2024 - 06/2005
15
Neck Dissection (Radical Neck Dissection)
01/2021 - 12/2004
9
Re-Irradiation
01/2019 - 04/2011
6
Chemoradiotherapy
02/2023 - 01/2010
5
Neoadjuvant Therapy
01/2023 - 11/2012
4
Thyroidectomy
01/2018 - 11/2008
3
Glossectomy
12/2017 - 11/2013